HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip A Wolf Selected Research

Renin

5/2012Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study.
1/2010Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip A Wolf Research Topics

Disease

28Stroke (Strokes)
09/2016 - 05/2003
21Dementia (Dementias)
01/2016 - 02/2002
15Alzheimer Disease (Alzheimer's Disease)
01/2016 - 02/2002
11Hypertension (High Blood Pressure)
07/2016 - 10/2002
10Ischemic Stroke
09/2016 - 08/2003
10Cardiovascular Diseases (Cardiovascular Disease)
04/2015 - 10/2002
8Atrial Fibrillation
04/2015 - 02/2004
7Inflammation (Inflammations)
02/2015 - 09/2007
6Cognitive Dysfunction
07/2016 - 09/2009
6Atherosclerosis
08/2009 - 03/2004
4Brain Injuries (Brain Injury)
06/2015 - 07/2004
4Brain Infarction
05/2015 - 05/2008
4Transient Ischemic Attack
10/2013 - 02/2004
3Insulin Resistance
06/2015 - 08/2011
3Cerebrovascular Trauma
10/2013 - 09/2009
3Carotid Stenosis (Carotid Artery Stenosis)
11/2008 - 11/2006
3Carotid Artery Diseases
11/2008 - 10/2002
3Pathologic Constriction (Stenosis)
11/2008 - 10/2004
3Coronary Disease (Coronary Heart Disease)
04/2008 - 05/2003
2Atrophy
07/2016 - 05/2014
2Diabetes Mellitus
04/2015 - 10/2002
2Myocardial Infarction
02/2015 - 03/2014
2Neoplasms (Cancer)
03/2014 - 01/2007
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
07/2013 - 04/2008
2Obesity
02/2013 - 05/2006
2Heart Failure
11/2011 - 02/2004
2Glucose Intolerance
07/2006 - 11/2005
1Hyperglycemia
06/2015
1Memory Disorders (Memory Loss)
04/2015
1Cerebral Small Vessel Diseases
02/2015
1Cerebral Infarction
02/2015
1Hyperhomocysteinemia
03/2014
1Vascular Diseases (Vascular Disease)
05/2012
1Cataract (Cataracts)
01/2012

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
09/2016 - 01/2007
14HomocysteineIBA
02/2015 - 02/2002
13ApolipoproteinsIBA
07/2016 - 03/2002
11Apolipoproteins E (ApoE)IBA
01/2016 - 05/2003
6C-Reactive ProteinIBA
02/2015 - 10/2002
5Apolipoprotein E4IBA
04/2015 - 07/2010
5HDL CholesterolIBA
02/2015 - 10/2002
4CholesterolIBA
02/2015 - 05/2003
4Insulin (Novolin)FDA Link
05/2014 - 11/2006
4AlbuminsIBA
05/2012 - 07/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2016 - 10/2013
3Glucose (Dextrose)FDA LinkGeneric
06/2015 - 11/2006
3Antihypertensive Agents (Antihypertensives)IBA
04/2015 - 11/2005
3Fibrinogen (Factor I)FDA Link
02/2015 - 03/2004
3VitaminsIBA
03/2014 - 10/2005
3Indicators and Reagents (Reagents)IBA
12/2013 - 04/2008
3Brain Natriuretic Peptide (Natrecor)FDA Link
05/2012 - 02/2004
3Natriuretic PeptidesIBA
05/2012 - 02/2004
3Hormones (Hormone)IBA
06/2010 - 04/2008
2Type II Tumor Necrosis Factor ReceptorsIBA
09/2016 - 02/2015
2Blood Glucose (Blood Sugar)IBA
01/2016 - 06/2015
2Peptides (Polypeptides)IBA
03/2015 - 02/2004
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
02/2015 - 05/2012
2Triglycerides (Triacylglycerol)IBA
02/2015 - 05/2006
2Folic Acid (Vitamin M)FDA LinkGeneric
03/2014 - 10/2005
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2014 - 10/2013
2EnzymesIBA
11/2012 - 04/2012
2Lipoproteins (Lipoprotein)IBA
11/2012 - 11/2006
2ReninIBA
05/2012 - 01/2010
2fibrin fragment D (D-dimer)IBA
05/2012 - 01/2010
2AldosteroneIBA
05/2012 - 01/2010
2Docosahexaenoic AcidsIBA
05/2012 - 11/2006
2Matrix Metalloproteinases (MMPs)IBA
12/2010 - 11/2008
2Tissue Inhibitor of Metalloproteinase-1IBA
12/2010 - 11/2008
2Estrogens (Estrogen)FDA Link
04/2009 - 01/2005
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2008 - 10/2004
2Hemostatics (Antihemorrhagics)IBA
07/2006 - 03/2004
2Warfarin (Coumadin)FDA LinkGeneric
10/2004 - 08/2003
2Proteins (Proteins, Gene)FDA Link
03/2004 - 02/2004
1Particulate MatterIBA
05/2015
1Amyloid (Amyloid Fibrils)IBA
03/2015
1P-SelectinIBA
02/2015
1OsteoprotegerinIBA
02/2015
1CD40 Ligand (CD40L)IBA
02/2015
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2015
1Interleukin-6 (Interleukin 6)IBA
02/2015
1Peroxidase (Myeloperoxidase)IBA
02/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2015
1LipidsIBA
02/2015
1LDL CholesterolIBA
02/2015
1oxidized low density lipoproteinIBA
02/2015
1Carbon MonoxideIBA
11/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
05/2014
1Methionine (L-Methionine)FDA Link
03/2014
1CarbonIBA
03/2014
1P-2 (P 2)IBA
02/2014
1CytokinesIBA
01/2013
1Plasminogen Activator Inhibitor 1IBA
05/2012
1CreatinineIBA
05/2012
1AdiponectinIBA
05/2012
1Delta CateninIBA
01/2012
1CateninsIBA
01/2012

Therapy/Procedure

3Secondary Prevention
01/2011 - 06/2004
2Institutionalization (Institutionalized Persons)
04/2009 - 05/2003
1Caloric Restriction
01/2014